Wf. Elmquist et al., TRANSSYNOVIAL DRUG DISTRIBUTION - SYNOVIAL MEAN TRANSIT-TIME OF DICLOFENAC AND OTHER NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Pharmaceutical research, 11(12), 1994, pp. 1689-1697
The synovial mean transit time of diclofenac was determined by two met
hods from existing plasma and synovial fluid concentration-time data.
These data were obtained from single- and multiple-dosing regimens of
diclofenac in patients with osteoarthritis and rheumatoid arthritis. P
lasma and synovial fluid concentration-time data taken from the litera
ture for four other nonsteroidal antiinflammatory drugs (etodolac, ibu
profen, indomethacin, and tenoxicam) were also analyzed. The two metho
ds of data analysis rely on the determination of the ratio of the area
under the synovial fluid concentration time curve to the area under t
he plasma concentration-time curve. Both methods can be considered non
compartmental because in determining the first-order exit rate constan
t for the synovial fluid (the inverse of the synovial mean transit tim
e), an analysis of the overall distribution and elimination characteri
stics of the drug is unnecessary. Method 1 makes use of the informatio
n contained in the postdistributional synovial fluid to plasma concent
ration ratio whereas method 2 is a linear pharmacokinetic model using
a partial-areas analysis. The single dose mean +/- S.D. synovial fluid
exit rate constant for diclofenac was 0.39 +/- 0.33 hr(-1) (n = 6), w
hich was not significantly different from that determined by method 2;
which was 0.49 +/- 0.52 hr(-1). The steady state mean +/- S.D. diclof
enac synovial fluid exit rate constants for methods 1 and 2 were 0.43
+/- 0.18 and 0.54 +/- 0.71 hr(-1) (n = 8), respectively, which were no
t significantly different. These values of synovial fluid exit rate co
nstants result in a synovial mean transit time for diclofenac that is
approximately 2 to 2.5 hours. The synovial mean transit time calculate
d using method 1 from literature data for etodolac, ibuprofen, indomet
hacin, and tenoxicam were 6.8, 2.2, 4.8, and 3.5 hours, respectively.
The synovial mean transit times calculated by method 2 for the same dr
ugs were 5.3, 3.4, 4.7, and 4.0 hours, respectively. Similar values of
the synovial mean transit time of nonsteroidal antiinflammatory drugs
were achieved by using either of these two methods, both of which avo
id complex equation fitting which is statistically problematic in the
frequently data-sparse environment of extravascular sampling.